{"id":"W4383695818","doi":"10.3390/ph16070985","title":"[212Pb]Pb-eSOMA-01: A Promising Radioligand for Targeted Alpha Therapy of Neuroendocrine Tumors","year":2023,"lang":"en","type":"article","venue":"Pharmaceuticals","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"TRIUMF","funders":"European Regional Development Fund","keywords":"Biodistribution; Radionuclide therapy; Radioligand; Chemistry; In vivo; Neuroendocrine tumors; Nuclear medicine; Spect imaging; Radiochemistry; Ex vivo; Receptor; In vitro; Internal medicine; Medicine; Biochemistry; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002889065,0.0002998024,0.000686706,0.0003791738,0.0001161156,0.00002815984,0.0002682106,0.0000091764,0.0002528924],"category_scores_gemma":[0.001041788,0.0002507208,0.0002438273,0.0009070932,0.0002464936,0.0001557058,0.0001151521,0.0003454473,0.00006889274],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004132658,"about_ca_system_score_gemma":0.0001499165,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006978596,"about_ca_topic_score_gemma":5.83545e-7,"domain_scores_codex":[0.9971048,0.0001232114,0.000592585,0.0005405181,0.0006140952,0.00102474],"domain_scores_gemma":[0.9981043,0.0006528939,0.0001297006,0.000422242,0.0001842816,0.0005065718],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00277757,0.0003922199,0.001855437,0.0006047004,0.0001697787,0.002900948,0.00007028023,0.00002742183,0.9712931,0.0002868762,0.006747087,0.01287456],"study_design_scores_gemma":[0.006823794,0.0007801546,0.001932822,0.00009381337,0.00004076992,0.00100819,0.00004729776,0.001754362,0.8760406,0.0005992884,0.1106859,0.0001930129],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9865676,0.001836536,0.00006441453,0.007296779,0.0002335411,0.002859653,0.00007439043,0.0004526053,0.0006144516],"genre_scores_gemma":[0.9942492,0.002172084,0.0007985638,0.001047773,0.0002684517,0.0002567862,0.00005428958,0.0001195448,0.001033257],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1039388,"threshold_uncertainty_score":0.9999945,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1071141108231488,"score_gpt":0.4352716562238662,"score_spread":0.3281575454007173,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}